Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLPHENIDATE Cause Cerebral atrophy? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Cerebral atrophy have been filed in association with METHYLPHENIDATE (Methylphenidate Hydrochloride). This represents 0.0% of all adverse event reports for METHYLPHENIDATE.

10
Reports of Cerebral atrophy with METHYLPHENIDATE
0.0%
of all METHYLPHENIDATE reports
0
Deaths
6
Hospitalizations

How Dangerous Is Cerebral atrophy From METHYLPHENIDATE?

Of the 10 reports, 6 (60.0%) required hospitalization, and 6 (60.0%) were considered life-threatening.

Is Cerebral atrophy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLPHENIDATE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLPHENIDATE Cause?

Drug ineffective (4,924) Off label use (4,842) No adverse event (4,197) Product quality issue (1,728) Disturbance in attention (1,414) Product substitution issue (1,408) Anxiety (1,356) Drug dose omission (1,330) Headache (1,255) Wrong technique in product usage process (1,250)

What Other Drugs Cause Cerebral atrophy?

FINGOLIMOD (87) VALPROIC ACID (84) PHENYTOIN (58) METHOTREXATE (55) LEVETIRACETAM (54) CYCLOPHOSPHAMIDE (52) OLANZAPINE (52) CARBIDOPA\LEVODOPA (50) VALPROATE (50) OCRELIZUMAB (48)

Which METHYLPHENIDATE Alternatives Have Lower Cerebral atrophy Risk?

METHYLPHENIDATE vs METHYLPREDNISOLONE METHYLPHENIDATE vs METHYLPREDNISOLONE ACEPONATE METHYLPHENIDATE vs METHYLPREDNISOLONE HEMISUCCINATE METHYLPHENIDATE vs METILDIGOXIN METHYLPHENIDATE vs METOCLOPRAMIDE

Related Pages

METHYLPHENIDATE Full Profile All Cerebral atrophy Reports All Drugs Causing Cerebral atrophy METHYLPHENIDATE Demographics